Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Thoracic Neoplasms and UGT1A1[original query] |
---|
Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A). Thoracic cancer 2017 Jan 8 (1): 40-45. Fukuda Minoru, Shimada Midori, Kitazaki Takeshi, Nagashima Seiji, Hashiguchi Kohji, Ebi Noriyuki, Takayama Koichi, Nakanishi Yoichi, Semba Hiroshi, Harada Taishi, Seto Takashi, Okamoto Isamu, Ichinose Yukito, Sugio Ken |
Relationship between UGT1A1*27 and UGT1A1*7 polymorphisms and irinotecan-related toxicities in patients with lung cancer. Thoracic cancer 2017 Oct . Fukuda Minoru, Okumura Manabu, Iwakiri Tomomi, Arimori Kazuhiko, Honda Takuya, Kobayashi Kazuma, Senju Hiroaki, Takemoto Shinnosuke, Ikeda Takaya, Yamaguchi Hiroyuki, Nakatomi Katsumi, Matsuo Nobuko, Mukae Hiroshi, Ashizawa Kazu |
Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study. Thoracic cancer 2023 9 . Hiromi Tomono, Hirokazu Taniguchi, Minoru Fukuda, Takaya Ikeda, Seiji Nagashima, Kazumasa Akagi, Sawana Ono, Yasuhiro Umeyama, Midori Shimada, Hiroshi Gyotoku, Shinnosuke Takemoto, Yasushi Hisamatsu, Ryotaro Morinaga, Ryuta Tagawa, Ryosuke Ogata, Yosuke Dotsu, Hiroaki Senju, Hiroshi Soda, Katsumi Nakatomi, Fumiko Hayashi, Nanae Sugasaki, Akitoshi Kinoshita, Hiroshi Muk |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: